Why rNPV is Preferred for Biopharmaceutical Valuation

The typical time taken for an Investigational New Drug (IND) from submission to introduction in the market is around eight years. Such long periods of development make the Biopharma industry unique. A biopharma drug does not generate any revenue during the initial years of development resulting in significantly negative cash flows.

Biopharma drug development has to […]

By |2019-09-08T23:52:49-05:30August 23rd, 2019|Fund Raising|Comments Off on Why rNPV is Preferred for Biopharmaceutical Valuation

AI in Financial Services is Here but a Lot More to Come

The application of AI has increased rapidly across industries to streamline operations, make more informed decisions, automate processes, and improve accuracy. Although the Financial Services industry is among the leaders in the adoption of AI, it is still a long way from fully tapping the benefits of AI. The adoption of AI in the Financial […]

By |2019-08-23T06:50:13-05:30August 6th, 2019|Financial, Startups|Comments Off on AI in Financial Services is Here but a Lot More to Come
Go to Top